Axolotl Digits Reveal New Pathways for Human Tissue Regeneration
Scientists decode how axolotl digits regrow, uncovering unique mechanisms that could revolutionize regenerative medicine.
20 articles
Scientists decode how axolotl digits regrow, uncovering unique mechanisms that could revolutionize regenerative medicine.
A rigorous mechanistic deep-dive into the molecular logic of partial reprogramming — from chromatin dynamics and epigenetic clock reversal to in vivo delivery strategies, oncogenic risks, and the path to clinical translation.
Master the cutting-edge molecular targets, clinical trial data, and emerging therapeutic strategies aimed at reversing ECM aging — from senolytic combinations to biomaterial scaffolds and epigenetic reprogramming.
Go beyond the basics and explore the precise molecular mechanisms by which Yamanaka factors remodel the epigenome, silence cell identity, and unlock pluripotency — with implications for partial reprogramming therapies.
Revolutionary nanotechnology approaches demonstrate 30% better drug delivery and enhanced muscle regeneration in preclinical studies.
Scientists discover non-canonical muscle stem cells in zebrafish and axolotls that could unlock new regenerative therapies for humans.
Comprehensive review reveals how parabiosis, organoids, and assembloids complement each other to model complex diseases from systemic to tissue levels.
Human stem cells that migrate through 3µm channels spontaneously begin differentiating into bone cells — no chemical signals required.
Comprehensive review of emerging single-cell technologies that simultaneously analyze DNA, RNA, and proteins from individual cells, revolutionizing cancer diagnosis and treatment.
Dive deep into partial reprogramming, niche remodeling, senolytics, and cutting-edge clinical therapies — the molecular toolkit for reversing stem cell aging.
Scientists converted fibroblasts into functional osteoblasts using small molecules, then formed transplantable spheroids that repair bone defects without scaffolding.
A cross-species bacterial genome editing platform achieves >90% efficiency in two species, opening doors for microbiome and probiotic engineering.
A landmark review maps the three pillars of modern lineage tracing and how they're reshaping our understanding of cell fate decisions.
New review explores how lab-grown organ models are revolutionizing personalized medicine and drug development.
Discover how revolutionary drugs target 'zombie cells' that accumulate with age, potentially reversing aging and extending healthspan.
Master the cutting-edge molecular pharmacology of Wnt pathway modulation — from small-molecule β-catenin activators to senescence-driven inhibitor networks — and understand how researchers are translating these mechanisms into regenerative therapies.
New research reveals how a key protein's behavior changes during intestinal cell development, offering insights into tissue regeneration.
Kyoto researchers created jawbone-like organoids from human iPSCs, recapitulating mandibular development and modeling fragile bone disease.
New engineered vesicles called hybrosomes may overcome key limitations of exosome therapy for skin regeneration and anti-aging treatments.
A new Nature Biotechnology review maps how large-scale AI foundation models are transforming biomedicine, from genomics to clinical diagnostics.